Current Challenges and Opportunities in Treating Glioblastoma.

Pharmacol Rev · 2018 · PMC5907910 · PMID 29669750

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

borderline significanceP value = 0.065so close (0.05 < p ≤ 0.1)

All but one gene ( NDEL1 ) remained significant ( P value <0.05) after controlling for significant clinical properties, but still exhibited borderline significance ( P value = 0.065).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.